Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Artemis: guarding small children and, now, the genome
Vicky L. Brandt, David B. Roth
Vicky L. Brandt, David B. Roth
Published February 1, 2003
Citation Information: J Clin Invest. 2003;111(3):315-316. https://doi.org/10.1172/JCI17743.
View: Text | PDF
Commentary

Artemis: guarding small children and, now, the genome

  • Text
  • PDF
Abstract

Authors

Vicky L. Brandt, David B. Roth

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
(a) V(D)J recombination is initiated when the RAG1 and RAG2 proteins bin...
(a) V(D)J recombination is initiated when the RAG1 and RAG2 proteins bind to specific recognition sequences (triangles) that flank the Ig or T cell receptor gene segments (rectangles, here denoted V and J). The RAG proteins act in concert to cleave the DNA precisely between the specific recognition sequences and the coding segments, producing blunt signal ends and covalently sealed (hairpinned) coding ends. The latter must be opened by endonucleolytic cleavage before forming the coding joint (the rearranged antigen-receptor gene). RAG1/RAG2 and NHEJ factors (listed in the center of the figure) are required for forming both coding and signal joints; DNA-PKcs and Artemis have special roles in creating coding joints, although DNA-PKcs–deficient cells show some abnormal signal joints and a mild decrease in signal joint formation as well. (b) Hairpin opening requires several factors, including Artemis, DNA-PKcs, and possibly the RAG proteins. The hairpins are nicked near the terminus, generating short single-strand extensions; terminal deoxynucleotidyl transferase (TdT) can be recruited to the site to insert N nucleotides, creating added junctional diversity.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts